AG00E8SY

60607-34-3 | Oxatomide

Chemical structure of Oxatomide, CAS 60607-34-3
AG00E8SY
sdsSDS
sdsCOA
TIP This product is typically in stock.Please contact us for quotation.
Request For Quotation

CAS Number 60607-34-3
Catalog Number AG00E8SY(AGN-PC-0SWU3L)
Chemical Name Oxatomide
EC Number 262-320-9
IUPAC Name 3-[3-(4-benzhydrylpiperazin-1-yl)propyl]-1H-benzimidazol-2-one
InChI InChI=1S/C27H30N4O/c32-27-28-24-14-7-8-15-25(24)31(27)17-9-16-29-18-20-30(21-19-29)26(22-10-3-1-4-11-22)23-12-5-2-6-13-23/h1-8,10-15,26H,9,16-21H2,(H,28,32)
InChI Key BAINIUMDFURPJM-UHFFFAOYSA-N
MDL Number MFCD00211147
Molecular Formula C27H30N4O
Molecular Weight 426.5533
NSC Number 309710
SMILES C(C1=CC=CC=C1)(C1=CC=CC=C1)N1CCN(CC1)CCCN1C(NC2=C1C=CC=C2)=O
UNII J31IL9Z2EE
Synonyms
KW 4354, KW-4354, oxatimide, oxatomide, R 35443, R35443, Tinset, oxatomide, 60607-34-3, Tinset, Oxatimide, Oxatomida, Celtect, Oxetal, KW-4354, Oxatomidum [INN-Latin], Oxatomida [INN-Spanish], McN-JR 35443, R 35443, UNII-J31IL9Z2EE, 3-[3-(4-benzhydrylpiperazin-1-yl)propyl]-1H-benzimidazol-2-one, 1-[3-[4-(Diphenylmethyl)-1-piperazinyl]propyl]-1,3-dihydro-2H-benzimidazol-2-one, C27H30N4O, 1-(3-(4-Benzhydrylpiperazin-1-yl)propyl)-1H-benzo[d]imidazol-2(3H)-one, EINECS 262-320-9, R-35443, BRN 4724760, J31IL9Z2EE, 1-(3-(4-(Diphenylmethyl)-1-piperazinyl)propyl)-1,3-dihydro-2H-benzimidazol-2-one, MLS000028549, BAINIUMDFURPJM-UHFFFAOYSA-N, 1-(3-(4-(Diphenylmethyl)-1-piperazinyl)propyl)-2-benzimidazolinone, R 35,443, NCGC00015774-03, Oxatomidum, SMR000058301, 1-[3-[4-(Diphenylmethyl)-1-piperazinyl]propyl]-2-benzimidazolinone, DSSTox_CID_25181, DSSTox_RID_80729, DSSTox_GSID_45181, W-105243, 3-[3-[4-(diphenylmethyl)-1-piperazinyl]propyl]-1H-benzimidazol-2-one, 3-[3-[4-(diphenylmethyl)piperazin-1-yl]propyl]-1H-benzimidazol-2-one, 2H-Benzimidazol-2-one, 1,3-dihydro-1-(3-(4-(diphenylmethyl)-1-piperazinyl)propyl)-, 2H-Benzimidazol-2-one, 1-(3-(4-(diphenylmethyl)-1-piperazinyl)propyl)-1,3-dihydro-, Oxatomide (tinset), Celtect (TN), CAS-60607-34-3, Oxatomide [USAN:BAN:INN:JAN], CBMicro_024634, KW 4354, Cobiona, Dasten, Oxatomide (JAN/USAN/INN), 1-{3-[4-(diphenylmethyl)-1-piperazinyl]propyl}-1,3-dihydro-2H-benzimidazol-2-one, Oxatomide [USAN:INN:BAN:JAN], R35443, Oxatomide, >=99%, AC1L1IKA, Lopac-O-9387, O 9387, cid_4615, Lopac0_000924, Oprea1_338592, REGID_for_CID_4615, SCHEMBL28824, CHEMBL13828, DTXSID4045181, BDBM76863, CHEBI:31943, CTK7H0209, HMS2089N07, HMS2231H12, HMS3372K08, Tox21_110219, CCG-11811, MFCD00211147, NSC309710, ZINC19632896, 1-[3-(4-Benzhydryl-piperazin-1-yl)-propyl]-1,3-dihydro-benzoimidazol-2-one, AKOS000507212, Tox21_110219_1, AB04841, API0024517, DB12877, KS-1375, NSC-309710, VA11458, NCGC00015774-01, NCGC00015774-02, NCGC00015774-04, NCGC00015774-05, NCGC00015774-06, NCGC00094235-01, NCGC00094235-02, AJ-74101, AN-39436, BAS 01509783, LS-33365, SC-17011, BIM-0024581.P001, AX8146443, EU-0100924, FT-0630723, ST50253168, D01773, 54331-EP2308562A2, 54331-EP2371811A2, AB01227629-02, 607O343, A832804, SR-01000076051, I06-0696, SR-01000076051-1, 1-[3-[4-(DIPHENYLMETHYL)-1-PIPERAZINYL]PROPYL]-1,3, 3-[3-(4-benzhydrylpiperazino)propyl]-1H-benzimidazol-2-one, 1-{3-[4-(diphenylmethyl)piperazinyl]propyl}-3-hydrobenzimidazol-2-one, 1-[3-(4-benzhydrylpiperazin-1-yl)propyl]-1,3-dihydro-2H-benzimidazol-2-one, 1-{3-[4-(diphenylmethyl)-1-piperazinyl}-propyl}-1,3-dihydro-2H-benzimidazol-2-one, 1-{3-[4-(diphenylmethyl)piperazin-1-yl]propyl}-1,3-dihydro-2h-benzimidazol-2-one, 1{-[4-(diphenylmethyl)-1-piperzinyl]propyl}-1,3-dihydro-2H-benzimidazol-2-one, celtomide, D0AJ5L, CID4615, 2H-Benzimidazol-2-one,3-dihydro-, C27-H30-N4-O, CS-O-11702, C015408, R 35 443, 2H-Benzimidazol-2-one, 1-[3-[4-(diphenylmethyl)-1-piperazinyl]propyl]-1,3-dihydro-,

Related Research Chemicals

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited